To substantiate tear lactoferrin level evaluation as a potentially routine clinical biomarker to differentiate patients with DED with and without AI, we collected tear fluid from patients with non-Sjögren’s DED, SS-DED (including primary and secondary SS), and controls, and analyzed lactoferrin levels using a self-designed photo-detection device. The gene discussed is LTF; the disease is synovial sarcoma.